Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.91B |
| 2 |
SPCX
SpaceX
SPCX
|
+$871M |
| 3 |
Eli Lilly
LLY
|
+$719M |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Netflix
NFLX
|
+$627M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.42B |
| 4 |
NVIDIA
NVDA
|
+$1.41B |
| 5 |
SNDK
Sandisk
SNDK
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.67% |
| 2 | Technology | 3.92% |
| 3 | Healthcare | 2.55% |
| 4 | Industrials | 2.24% |
| 5 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
DexCom
DXCM
$33.2B
| $81.6M | 0.01% |
1,211,767
-880,105
| -42% | -$58.6M |
|
1127
PUT
GameStop
GME
$10.9B
| $81.5M | 0.01% |
3,692,500
-1,686,200
| -31% | -$38.6M |
|
1128
CALL
ProShares UltraPro S&P 500
UPRO
$5.31B
| $81.4M | 0.01% |
573,800
-201,700
| -26% | -$26.7M |
|
1129
PUT
Estee Lauder
EL
$34.9B
| $80.9M | 0.01% |
1,024,700
+244,700
| +31% | +$19.8M |
|
1130
ACM Research
ACMR
$4.55B
| $80.8M | 0.01% |
636,836
+433,458
| +213% | +$30.6M |
|
1131
NRG Energy
NRG
$22.8B
| $80.6M | 0.01% |
552,159
+281,005
| +104% | +$40.5M |
|
1132
PUT
Abbott
ABT
$178B
| $80.6M | 0.01% |
887,900
+555,300
| +167% | +$50.7M |
|
1133
CALL
Cigna
CI
$74.8B
| $80.4M | 0.01% |
291,700
+99,400
| +52% | +$28.1M |
|
1134
CALL
Phillips 66
PSX
$106B
| $79.7M | 0.01% |
471,700
-50,100
| -10% | -$8.62M |
|
1135
Rivian
RIVN
$22.3B
| $79.4M | 0.01% |
4,578,186
+2,328,426
| +103% | +$36.3M |
|
|
DFTX
1136
Definium Therapeutics
DFTX
$5.21B
| $79.4M | 0.01% |
1,688,587
+355,145
| +27% | +$8.78M |
|
1137
PUT
Argan
AGX
$5.59B
| $79.3M | 0.01% |
99,300
+1,300
| +1% | +$865K |
|
1138
Cognizant
CTSH
$28.1B
| $79.1M | 0.01% |
2,043,590
-1,391,912
| -41% | -$73.3M |
|
1139
Prosperity Bancshares
PB
$8.55B
| $79.1M | 0.01% |
1,082,980
+984,426
| +999% | +$68.5M |
|
1140
Rollins
ROL
$16.5B
| $79M | 0.01% |
1,893,415
+1,748,668
| +1,208% | +$89.4M |
|
1141
PUT
T-Mobile US
TMUS
$191B
| $79M | 0.01% |
471,100
-181,400
| -28% | -$34.3M |
|
1142
Sanofi
SNY
$103B
| $79M | 0.01% |
1,852,207
+364,237
| +24% | +$16.3M |
|
1143
State Street SPDR S&P Biotech ETF
XBI
$10.5B
| $79M | 0.01% |
+499,184
| New | +$67.5M |
|
1144
Prologis
PLD
$129B
| $78.8M | 0.01% |
581,773
+79,967
| +16% | +$11.3M |
|
1145
Acadia Healthcare
ACHC
$2.61B
| $78.7M | 0.01% |
2,665,603
-50,822
| -2% | -$1.3M |
|
|
FRMI
1146
Fermi Inc
FRMI
$3.16B
| $78.7M | 0.01% |
8,587,055
+2,365,349
| +38% | +$15M |
|
1147
ICU Medical
ICUI
$3.95B
| $78.6M | 0.01% |
536,225
+202,889
| +61% | +$26.5M |
|
1148
PUT
Corpay
CPAY
$26.6B
| $78.6M | 0.01% |
235,800
+232,900
| +8,031% | +$77.4M |
|
1149
CALL
Energy Transfer Partners
ET
$73.2B
| $78.6M | 0.01% |
4,109,800
+969,200
| +31% | +$18.8M |
|
1150
CALL
BHP
BHP
$217B
| $78.6M | 0.01% |
943,100
-292,000
| -24% | -$24.2M |
|
Similar funds
Citadel Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
- Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
- Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
- Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
- Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
- Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.